Metastatic Melanoma may be Treated by Targeted Drug-Combo

by Kathy Jones on  June 5, 2011 at 1:00 AM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

New research indicates that combining two drugs that target a prime survival strategy of tumors, can be safely administered and this is potentially more effective than either drug alone for advanced and inoperable melanomas.
 Metastatic Melanoma may be Treated by Targeted Drug-Combo
Metastatic Melanoma may be Treated by Targeted Drug-Combo

The drugs-ipilimumab and bevacizumab-are both monoclonal antibodies, intensified formulations of natural disease-fighting proteins.

Ipilimumab spurs the immune system to attack diseased cells, including tumor cells. Bevacizumab, also known by the trade name Avastin, blocks the growth of blood vessels that provide tumors with nourishment.

Ipilimumab has extended the lives of metastatic melanoma patients in previous clinical trials, and bevacizumab is often used to treat tumors of the colon, lung, and kidney.

"Our findings indicate that ipilimumab and bevacizumab can be safely administered with careful management of side effects," said F. Stephen Hodi, MD, the study's lead author and director of the melanoma treatment center at Dana-Farber.



Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Skin Cancer Ultra-Violet Radiation Melanoma 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...